Usefulness of the systemic immune-inflammation index in predicting atrial fibrillation recurrence after direct current cardioversion.

Abstract

Background: We aimed to determine whether there is a relationship between the systemic immune-inflammation (SII) index and the recurrence of atrial fibrillation (AF) after successful direct current cardioversion (DCCV). Methods: The study included 99 patients with persistent AF who underwent successful cardioversion between 2015 and 2020. Results: In multiple regression analyses, the SII index was found to be a better independent predictor of AF recurrence after successful DCCV (p < 0.001). The cut-off value of SII (563) was associated with 96.9% sensitivity and 55.2% specificity to predict AF recurrence after DCCV. Conclusion: As a simple biomarker, SII index is an independent parameter for predicting AF recurrence after successful DCCV in patients with persistent AF. Also, SII levels can predict AF recurrence better than neutrophil-to-lymphocyte ratio.

• Authors: Görkem Kuş, Göksel Çağırcı, Nermin Bayar, Edip C Özgünoğlu, Ramazan Güven, Şakir Arslan
• Journal: Biomarkers in medicine (Biomark Med) Vol. 16 Issue 11 Pg. 847-855 (08 2022) ISSN: 1752-0371 [Electronic] England
• PMID: 35833842 (Publication Type: Journal Article)

Topics

• Atrial Fibrillation (diagnosis, therapy)
• Electric Countershock
• Humans
• Inflammation
• Recurrence
• Treatment Outcome